Salix Pharm., Ltd. Stockholder Litig. v. Chappell, 155 A.3d 832 (2017)

Jan. 26, 2017 · Delaware Court of Errors and Appeals · No. 308, 2016
155 A.3d 832

SALIX PHARMACEUTICALS, LTD. STOCKHOLDER LITIGATION

Roberta Feinstein and Rex Gonsalves, Plaintiffs Below Appellants,
v.
John F. Chappell, Thomas W. D'Alonzo, William P. Keane, Mark A. Sirgo, Valeant Pharmaceuticals International, Inc., Valeant Pharmaceuticals International, and Sun Merger Sub, Inc., Defendants Below, Appellees.

No. 308, 2016

Supreme Court of Delaware.

Submitted: January 25, 2017
Decided: January 26, 2017

ORDER

Leo E. Strine, Jr., Chief Justice

This 26th day of January 2017, it appears to the Court that the judgment of the Court of Chancery should be affirmed for the reasons stated in its May 19, 2016 bench ruling.

NOW, THEREFORE, IT IS ORDERED that the judgment of the Court of Chancery is hereby AFFIRMED.